Subsequent studies indicated that ICP22 has a significant inhibitory effect on the activation of NF-κB-responsive promoter, which was further confirmed in the context of viral infection using ICP22 deficient HSV-2. This evidence concerns the gene NFKB1 and viral infectious disease.